Goldman Sachs Maintains a 'Neutral' on MAKO Surgical (MAKO); Updating Estimates

Goldman Sachs maintains a 'Neutral' on MAKO Surgical (NASDAQ: MAKO) price target of $15.00.

Analyst, David H. Roman, said, "We are updating our 2013 quarterly estimates to reflect greater hip procedure volumes and R&D spending in the first half of 2013, and less in the second half of the year. Our full-year 2013 procedure and R&D estimates remain essentially unchanged."

The changes aren't material and FY13 EPS estimate ends up being (0.54) from (0.53).

For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.

Shares of MAKO Surgical closed at $17.27 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stifel Upgrades Adidas AG (ADS:GR) (ADDYY) to Buy
• Elisa Oyj (ELISA:FH) (ELMUF) PT Lowered to EUR57 at JPMorgan
• Mizuho Upgrades Airbnb Inc. (ABNB) to Buy